The best perinatal depression screening: Is self-administered PHQ2 more feasible than a nurse-administered one?

Sarah Reinstein, Kate Lieb, Peter S. Bernstein, Chavi Eve Karkowsky

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Purpose: To assess perinatal depression screening via self-administered PHQ2 (SAP) vs nurse-administered PHQ2 (NAP). Design and Methods: NAP screening was performed for 3 months, followed by SAP. Data were gathered from visits at 24 to 28 weeks gestation. Findings: One hundred twenty-seven patients were in NAP arm, 100 in SAP arm. SAP had higher rates of screening (odds ratio [OR], 3.25; 95% confidence interval [CI], 1.63-6.49), but no difference in positive PHQ2 screens. The SAP rate of therapeutic action for positive screens was lower (OR, 0.24; 95% CI, 0.12-0.50). Practice Implications: SAP provided higher perinatal depression screening rates compared to NAP, but decreased therapeutic action.

Original languageEnglish (US)
Pages (from-to)81-85
Number of pages5
JournalPerspectives in Psychiatric Care
Volume56
Issue number1
DOIs
StatePublished - Jan 1 2020

Keywords

  • depression
  • postpartum period
  • pregnancy
  • screening method

ASJC Scopus subject areas

  • Phychiatric Mental Health

Fingerprint Dive into the research topics of 'The best perinatal depression screening: Is self-administered PHQ2 more feasible than a nurse-administered one?'. Together they form a unique fingerprint.

  • Cite this